Cohort study across five countries (28,122 people with dementia after MI): one or two of statin, RASI or beta-blocker carried similar recurrent MI and MACE risk to all three; only statin plus RASI showed similar mortality (HR 1.16, 0.97-1.39), other regimens higher.
Meta-analysisn = 288,482
Ilomäki et al. Secondary prevention of myocardial infarction in people with dementia: a multi-jurisdictional retrospective cohort study in Asia, Europe and the USA